Monopar Therapeutics MNPR
NASDAQ MNPR
$74.23 +2.76 (+3.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Acquisitions (2017)

Updated

Monopar Therapeutics (MNPR) posted Acquisitions of $1.00 for Q4 2017.

Analysis

Monopar Therapeutics (MNPR) Acquisitions (2017) Analysis & Trends

For FY2017, Monopar Therapeutics' Acquisitions came in at $4.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Monopar Therapeutics 635.73 Mn 353.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -1.00
API Access

Monopar Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=MNPR&period=max&api_key=YOUR_API_KEY